Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Frontiers in Oncology
|
November 29, 2023
Evolutionary reversion in tumorigenesis
Yosuke Nagahata, Hiroshi Kawamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 12, 2021
[The origin of blood cells and myeloid cells]
Yosuke Nagahata, Kyoko Masuda, Hiroshi Kawamoto
International Journal of Hematology
|
June 19, 2014
HIV-related NK/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity
Yosuke Nagahata, Aiko Kato, Yukihiro Imai, et al.
Internal Medicine (Tokyo, Japan)
|
June 4, 2013
The need for continuing chemotherapy for leukemic cell lysis pneumopathy in patients with acute myelomonocytic/monocytic leukemia
Aiko Kato, Yuichiro Ono, Yosuke Nagahata, et al.
Leukemia & Lymphoma
|
August 18, 2020
High-dose cytarabine chemotherapy (≥4 g/m<sup>2</sup>/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission
Yosuke Nagahata, Tadakazu Kondo, Yuichiro Ono, et al.
Nature Communications
|
June 15, 2019
Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection
Miki Arai Hojo, Kyoko Masuda, Hiroaki Hojo, et al.
Blood
|
September 16, 2022
Tracing the evolutionary history of blood cells to the unicellular ancestor of animals
Yosuke Nagahata, Kyoko Masuda, Yuji Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 28, 2026
Animals have expanded the evolutionary legacy of unicellular ancestors in blood cells
Yosuke Nagahata, Yuji Nishimura, Ryota Kaitani, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Frontiers in Oncology
|
November 29, 2023
Evolutionary reversion in tumorigenesis
Yosuke Nagahata, Hiroshi Kawamoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 12, 2021
[The origin of blood cells and myeloid cells]
Yosuke Nagahata, Kyoko Masuda, Hiroshi Kawamoto
International Journal of Hematology
|
June 19, 2014
HIV-related NK/T-cell lymphoma in the brain relapsed during intensive chemotherapy but regressed after chemotherapy discontinuation: the importance of maintaining cellular immunity
Yosuke Nagahata, Aiko Kato, Yukihiro Imai, et al.
Internal Medicine (Tokyo, Japan)
|
June 4, 2013
The need for continuing chemotherapy for leukemic cell lysis pneumopathy in patients with acute myelomonocytic/monocytic leukemia
Aiko Kato, Yuichiro Ono, Yosuke Nagahata, et al.
Leukemia & Lymphoma
|
August 18, 2020
High-dose cytarabine chemotherapy (≥4 g/m<sup>2</sup>/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission
Yosuke Nagahata, Tadakazu Kondo, Yuichiro Ono, et al.
Nature Communications
|
June 15, 2019
Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection
Miki Arai Hojo, Kyoko Masuda, Hiroaki Hojo, et al.
Blood
|
September 16, 2022
Tracing the evolutionary history of blood cells to the unicellular ancestor of animals
Yosuke Nagahata, Kyoko Masuda, Yuji Nishimura, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 28, 2026
Animals have expanded the evolutionary legacy of unicellular ancestors in blood cells
Yosuke Nagahata, Yuji Nishimura, Ryota Kaitani, et al.
Page
of 1